glp-1 receptor in brain Glucagon-like peptide-1 (GLP-1), released from the intestine, informs GLP-1R and Diabetes

Excess weight is strongly linked to sleep problems such as sleep apnea, which can cause: Frequent awakenings Poor sleep quality Daytime fatigue As weight decreases, breathing improves, inflammation decreases, and sleep quality often improves significantly

In STEP 8, mean body weight reduction was 6.4% with liraglutide 3.0 mg versus 15.8% with semaglutide 2.4 mg at 68 weeks

People with severe kidney, heart, or liver conditions need clearance from their primary doctor first

10.1016/j.physbeh.2009.08.013 Physiol

It is important to note that SGLT2 inhibitors are not licensed for use in type 1 diabetes in the UK

71, e230065